Case Summary (G.R. No. 271209)
Factual Background
PhilHealth issued Corporate Personnel Order No. 2018-1802 dated August 17, 2018, authorizing personnel of the Fact-Finding Investigation and Enforcement Department (FFIED) to conduct hospital spot inspections and claims validation through domiciliary visits within Regions IV-A, NCR, and Rizal from October 1 to 31, 2018, excluding Saturdays, Sundays, and holidays. WellMed Dialysis and Laboratory Center Corporation (WellMed) was among the medical centers subjected to the inspection and validation.
Based on an FFIED report, WellMed allegedly filed anomalous claims for patients who were already dead, while still receiving out-of-pocket payments from dialysis patients or members and allegedly not issuing the corresponding receipts for treatments. The FFIED report stated that on November 3, 2016, WellMed filed benefit claims for the out-patient hospitalization and dialysis sessions of PhilHealth member and patient Bebian Morte Albante (Albante) amounting to PHP 49,400.00, covering dialysis dates in August and September 2016. The records, however, established that Albante died on July 16, 2016, and was already dead when WellMed filed and processed the benefit claims. It was further alleged that Dr. Galauran certified, on behalf of WellMed, that Albante underwent dialysis sessions after July 16, 2016.
On these allegations, a Complaint-Affidavit was filed against Dr. Galauran and WellMed. FFIED charged Dr. Galauran with offenses of health care professionals under the Revised Implementing Rules and Regulations (RIRR) of the NHIA: (1) misrepresentation by furnishing false or incorrect information under Section 162, and (2) breach of the warranties of accreditation/performance commitment under Section 163.
Early Administrative Steps and Dr. Galauran’s Position
On July 12, 2019, PhilHealth ordered Dr. Galauran to file a Verified Answer. Dr. Galauran complied by filing a Verified Answer dated August 27, 2019, denying all accusations. He argued that he could not be held administratively liable because Albante was not his patient; that he was not a resident physician or consultant at WellMed; that he worked instead as an Associate Medical Doctor at Eaglerock Dialysis and Wellness Center, described as a direct competitor of WellMed; and that he had no participation in any alleged fraudulent claims because he did not sign any document for benefit claims submitted to PhilHealth.
The Accreditations Withdrawal and Subsequent Appeals Inside PhilHealth
Despite Dr. Galauran’s denial, PhilHealth issued a Letter dated August 7, 2020 (the first assailed order) informing him that his accreditation was withdrawn effective from the date of notice. The letter stated that, after investigation and on the basis of administrative cases filed before the Arbitration Office, PhilHealth found sufficient grounds to withdraw his accreditation. The charges were summarized in the first assailed order, including allegations of misrepresentation involving the filing of benefit claims for the hemodialysis sessions of a deceased patient and an alleged breach of the warranties stated in accreditation commitments, particularly vows to strictly abide by PhilHealth issuances, protect the National Health Insurance Program against abuse or over-utilization, and refrain from unethical or improper practices.
Dr. Galauran contested the withdrawal through a Letter dated September 4, 2020, seeking reconsideration. In addition to reiterating his earlier defenses, he asserted that he was a victim of WellMed’s alleged fraudulent machinations; that two WellMed whistleblowers purportedly admitted forging signatures for anomalous claims for “ghost dialysis”; that Albante’s mother’s Salaysay did not mention him as attending nephrologist; and that PhilHealth did not furnish him with a copy of the alleged falsified document or the document proving receipt by WellMed of specific amounts related to Albante’s treatments.
PhilHealth denied reconsideration through a Letter dated December 15, 2020 (the second assailed order), issued by the PhilHealth President and CEO, which emphasized that accreditation proceedings are separate and distinct from the quasi-judicial process. A Letter dated February 3, 2021 followed, informing Dr. Galauran of the decision of the PhilHealth President and CEO.
Petition for Certiorari Before the Court of Appeals
The assailed Orders prompted Dr. Galauran to file a petition for certiorari under Rule 65 with the CA. He argued that the Orders revoking his accreditation were unlawful because they were not issued by the PhilHealth Board of Directors (PhilHealth Board) acting in its quasi-judicial power. He further claimed that the withdrawal violated his constitutional right to due process because it was done without the requisite notice and hearing.
The parties submitted memoranda. In its memorandum, PhilHealth maintained that Dr. Galauran was administratively liable for multiple violations, thus justifying the accreditation withdrawal. Dr. Galauran denied the allegations and reiterated his defenses. He also informed the appellate court that the PhilHealth Arbitration Office dismissed the case against him for insufficiency of evidence via an Order dated May 31, 2022.
Ruling of the Court of Appeals
On September 13, 2023, the CA granted the petition and set aside the assailed Orders. It held that the authority to withdraw or revoke an existing accreditation is vested with the PhilHealth Board. It also clarified that the accreditation process and the revocation or withdrawal are separate processes carried out by distinct entities. Applying these principles, it ruled that Dr. Galauran’s accreditation was revoked arbitrarily and without lawful authority.
On due process, the CA found that PhilHealth violated Dr. Galauran’s rights. It held that PhilHealth failed to furnish him a copy of the document showing that he allegedly received PHP 6,650.00 from PhilHealth for the ghost dialysis sessions of Albante. The CA also concluded that the accreditation revocation was not supported by substantial evidence. It noted that documentary evidence showed that the deceased patient’s attending physician was Dr. Natividad, not Dr. Galauran, and that a computer-generated report only placed Dr. Galauran’s name in a list of professionals and did not prove that he prepared any report for Albante.
PhilHealth’s motion for reconsideration was denied by the CA in its Resolution dated December 13, 2023, which stated that the motion raised no compelling grounds and essentially rehashed matters already addressed.
Issues Raised in the Petition to the Supreme Court
PhilHealth sought reversal and presented two principal issues: first, whether Dr. Galauran’s accreditation was revoked arbitrarily and without lawful authority by the PhilHealth President and CEO and the Vice President; and second, whether Dr. Galauran was afforded due process.
The Parties’ Contentions in the Supreme Court
PhilHealth argued that it acted within jurisdiction and authority when the PhilHealth President and CEO, and the Vice President, withdrew Dr. Galauran’s accreditation, and not necessarily the PhilHealth Board. It reiterated that its accreditation procedure is separate and distinct from its arbitration procedure under the NHIA and the RIRR. It also claimed that Dr. Galauran was afforded due process.
Legal Basis and Reasoning of the Supreme Court
The Court affirmed the CA. It ruled that PhilHealth arbitrarily and unlawfully revoked Dr. Galauran’s accreditation and failed to afford him due process. Consequently, the CA did not commit grave abuse of discretion in setting aside PhilHealth’s assailed Orders.
The Court first established the governing legal framework for accreditation of health care professionals and the withdrawal and/or revocation of accreditation. It emphasized that under the NHIA, PhilHealth must determine requirements and issue guidelines for accreditation of health care providers and administer the Program. Under the NHIA and the RIRR, a health care provider is defined as a duly licensed professional accredited by PhilHealth. The RIRR defines “accreditation” as a process verifying qualifications and capabilities for participation in the Program and for assuring quality. The RIRR further requires, for accreditation, that the health care professional be duly licensed and meet other requirements, including compliance with performance commitment provisions and other requirements determined by PhilHealth.
The Court stressed that the RIRR recognizes continuous accreditation given to accredited providers who qualify for uninterrupted participation until accreditation is withdrawn based on rules set by PhilHealth. It cited the RIRR provision that accreditation matters involve an evaluation by an Accreditation Committee, whose decision becomes effective upon approval by the President and CEO, and that decisions may be the subject of a motion for reconsideration to the Accreditation Committee.
Most critically, the Court invoked the RIRR’s explicit allocation of quasi-judicial powers. Under Section 75 of the RIRR, PhilHealth is vested with quasi-judicial powers subject to the respondent’s right to due process, including the authority to suspend temporarily, revoke permanently, or restore accreditation after due notice and hearing. The Court held that these quasi-judicial powers are exercised by the PhilHealth Board, a collegial body. It also stated that when the PhilHealth Board decides on cases brought to it for review, whether en banc or in division, majority concurrence is required.
Applying these provisions, the Court found no merit in PhilHealth’s claim that the President and CEO possessed quasi-judicial power to revoke or withdraw accreditation. PhilHealth relied on Section 31 of the NHIA (authority to grant accreditation) and on certain accreditation process provisions, including RIRR provisions concerning how accreditation decisions become effective upon approval by the President
...continue reading
Case Syllabus (G.R. No. 271209)
Parties and Procedural Posture
- PhilHealth, represented by the PhilHealth President and Chief Executive Officer and the PhilHealth Regional Office-National Capital Region Vice President, petitioned for review on certiorari assailing the Court of Appeals (CA) Decision and Resolution in CA-G.R. SP No. 169097.
- Dr. Jose Mari Del Valle Galauran contested PhilHealth’s withdrawal of his accreditation as a health care professional (HCP) before the CA through a petition for certiorari under Rule 65.
- The CA granted Dr. Galauran’s petition and set aside the assailed PhilHealth letters withdrawing his accreditation.
- The CA denied PhilHealth’s motion for reconsideration for lack of merit, prompting PhilHealth’s petition to the Supreme Court.
- The Supreme Court affirmed the CA, holding that PhilHealth acted arbitrarily and unlawfully and denied due process to Dr. Galauran.
Parties’ Legal Positions
- PhilHealth maintained that the President and Chief Executive Officer, and the Vice President, acted within jurisdiction and authority when they withdrew Dr. Galauran’s accreditation.
- PhilHealth also asserted that its accreditation procedure is separate and distinct from its quasi-judicial/arbitration process under the NHIA and its RIRR.
- PhilHealth argued that Dr. Galauran was afforded due process, and it sought a temporary restraining order and/or writ of preliminary injunction before the Supreme Court to prevent alleged adverse consequences to the accreditation system.
- Dr. Galauran argued that the assailed orders revoking his accreditation were patently unlawful for not being issued by the PhilHealth Board in the exercise of its quasi-judicial power.
- Dr. Galauran further argued that the revocation violated his constitutional right to due process due to lack of proper notice and hearing.
Key Factual Allegations
- PhilHealth issued Corporate Personnel Order No. 2018-1802 authorizing personnel of the Fact-Finding Investigation and Enforcement Department (FFIED) to conduct hospital spot inspections and claims validation through domiciliary visits within specified regions during a defined period.
- WellMed Dialysis and Laboratory Center Corporation (WellMed) was among the medical centers subjected to such inspections and validations.
- FFIED reported that WellMed filed anomalous claims, including claims for patients who were already dead, and that it allegedly received payments from dialysis patients or members without issuing corresponding receipts.
- FFIED alleged that WellMed filed benefit claims regarding out-patient hospitalization and dialysis sessions of PhilHealth member and patient Bebian Morte Albante (Albante) amounting to PHP 49,400.00, covering specified dates in August and September 2016.
- The records established that Albante died on July 16, 2016, and thus was already dead when WellMed filed and processed the benefit claims.
- The allegations further claimed that Dr. Galauran certified, on behalf of WellMed, that Albante underwent dialysis sessions after July 16, 2016.
- A Complaint-Affidavit was filed against Dr. Galauran and WellMed, charging Dr. Galauran with misrepresentation and breach of warranties of accreditation/performance commitment under the Revised Implementing Rules and Regulations (RIRR) of the NHIA.
Charges under NHIA RIRR
- PhilHealth charged Dr. Galauran with misrepresentation by false or incorrect information under Section 162 of the RIRR.
- PhilHealth also charged Dr. Galauran with breach of the warranties of accreditation/performance commitment under Section 163 of the RIRR.
- The complaint’s focus on Dr. Galauran’s alleged certification centered on statements purportedly indicating that dialysis sessions occurred after Albante’s death.
Administrative Proceedings and Assailed Orders
- PhilHealth ordered Dr. Galauran to file a Verified Answer.
- Dr. Galauran filed a Verified Answer dated August 27, 2019 and denied the accusations.
- Dr. Galauran’s defenses included the claims that Albante was not his patient, that he was not a resident physician nor a consultant at WellMed, and that he worked as an Associate Medical Doctor at Eaglerock Dialysis and Wellness Center.
- Dr. Galauran also asserted lack of participation, stating he did not sign documents for the benefit claims to PhilHealth.
- PhilHealth later issued a Letter dated August 7, 2020 (the first assailed Order) informing Dr. Galauran that his accreditation was withdrawn effective from the date of notice.
- The first assailed Order stated that, after investigation and based on administrative cases before the Arbitration Office, PhilHealth found sufficient grounds to withdraw his accreditation.
- Dr. Galauran received charges summarized in the first assailed Order, including alleged misrepresentation connected to a schedule of hospitalization and dialysis sessions attributed to the deceased Albante, and alleged breach of performance commitment provisions he had agreed to.
- Dr. Galauran contested the withdrawal through a letter seeking reconsideration, reiterating his prior defenses and adding that he was a victim of fraudulent machinations by WellMed and referencing alleged public admissions by whistleblowers and a Salaysay allegedly not mentioning his name.
- Dr. Galauran also argued that PhilHealth did not furnish copies of the alleged falsified document or proof of his receipt of PHP 6,500.00.
- The PhilHealth President and CEO denied the appeal through a Letter dated December 15, 2020 (the second assailed Order), emphasizing that accreditation is separate from the quasi-judicial process.
- PhilHealth informed Dr. Galauran of the final decision through a subsequent letter dated February 3, 2021.
CA Review under Rule 65
- Dr. Galauran filed a Rule 65 petition for certiorari before the CA to challenge the legality of the assailed Orders.
- He argued that the revocation was unlawful because it was not issued by the PhilHealth Board acting in its quasi-judicial power.
- He also argued that the revocation violated his due process rights for lack of proper notice and hearing.
- The CA resolved the petition on the basis of the parties’ submissions, including memoranda and a manifestation that the PhilHealth Arbitration Office had dismissed the case against him for insufficiency of evidence per an Order dated May 31, 2022.
CA Findings and Reasoning
- The CA set aside both assailed letters withdrawing Dr. Galauran’s accreditation.
- The CA ruled that authority to withdraw or revoke existing accreditation vested with the PhilHealth Board, not with the President